This chapter discusses prostatic artery embolization for benign prostatic hyperplasia. Benign prostatic hyperplasia (BPH) has a high rate of prevalence of less than 50% in men older than 50 years, which increases to less than 90% by the age of 80 years. The main symptoms are low urinary tract symptoms (LUTS) such as hesitancy, low flow, and intermittent stream, the sensation of poor bladder emptying, frequency, nocturia, urgency, and retention. Transurethral resection of the prostate (TURP) is still the gold standard treatment for BPH although it can be treated with medical therapy. This chapter also covers the preprocedure evaluation and indications of BPH.